Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2002
10/02/2002EP1244774A2 Pak5 a member of the p21-activated kinase (pak) protein family, nucleic acids and methods related to the same
10/02/2002EP1244773A1 Mutated hepatitis b virus, its nucleic and protein constituents and uses thereof
10/02/2002EP1244708A1 Method for treating inflammation
10/02/2002EP1244706A2 Method for production of a c1 esterase inhibitor (c1-inh)-containing composition
10/02/2002EP1244705A2 Serpentine transmembrane antigens expressed in human prostate cancers and uses thereof
10/02/2002EP1244704A1 Methods of inhibiting the binding of a cd8+ t cell to a class i mhc employing a modified beta 2 microglobulin
10/02/2002EP1244702A2 A process for isolation of osteopontin from milk
10/02/2002EP1244701A1 Transferrin polynucleotides, polypeptides, and antibodies
10/02/2002EP1244700A2 Vesicle trafficking proteins
10/02/2002EP1244697A2 Novel polypeptides and nucleic acids encoding same
10/02/2002EP1244695A2 Extracellular matrix and cell adhesion proteins as well as genes encoding them
10/02/2002EP1244693A1 Compositions for treating abnormalities in glomerular filtration, patent ductus arteriosus and osteoporosis
10/02/2002EP1244689A2 Cytokine polypeptides and nucleic acids
10/02/2002EP1244688A1 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
10/02/2002EP1244686A1 Transforming growth factor alpha hiii
10/02/2002EP1244685A1 Four disulfide core domain-containing (fdcd) polynucleotides, polypeptides, and antibodies
10/02/2002EP1244683A1 21 human secreted proteins
10/02/2002EP1244670A1 Hydantoin derivative compounds, pharmaceutical compositions, and methods of using same
10/02/2002EP1244630A1 Amphiphilic polyamines, the use and method for synthesis thereof
10/02/2002EP1244624A1 Anthracene derivatives as anti-cancer agents
10/02/2002EP1244471A1 Liquid composition of biodegradable block copolymer for drug delivery system and process for the preparation thereof
10/02/2002EP1244470A2 Use of heat shock proteins to enhance production of chemokines by a cell
10/02/2002EP1244468A2 Selective activation of a th1 or th2 lymphocyte regulated immune response
10/02/2002EP1244467A1 Phosphoglycerate kinase in the treatment of disease
10/02/2002EP1244466A2 Activation and inhibition of the immune system
10/02/2002EP1244462A2 Pharmaceutical composition comprised of spider venoms, the production thereof, and its use for treating tumor diseases
10/02/2002EP1244461A2 INHIBITION OF GSK-3$g(b)
10/02/2002EP1244455A1 Methods of treating vascular diseases characterized by nitric oxide insufficiency
10/02/2002EP1244433A2 Inhibitors of the inositol polyphosphate 5-phosphatase ship2 molecule
10/02/2002EP1244432A2 Methods for pulmonary delivery of interleukin-2
10/02/2002EP1244427A2 Pharmaceutical compositions for oral administration
10/02/2002EP1244388A2 Intervertebral disc treatment devices and methods
10/02/2002EP1244356A1 Compositions and methods for l-nucleosides, l-nucleotides, and their analogs
10/02/2002EP1244351A1 Animal models for neurodegenerative disease
10/02/2002EP1244350A2 Prostatic cell line and use thereof to obtain an established prostatic cancer in an animal
10/02/2002EP1077068B9 Utilization of interferon alpha 5 in the treatment of viral hepatopathies
10/02/2002EP1047450B1 Ace inhibitor-mmp inhibitor combinations
10/02/2002EP1007062A4 Therapeutic use of hemoglobin to treat head injury
10/02/2002EP0871465B1 Use of ritonavir (abt-538) for improving the pharmacokinetics of drugs metabolized by cytochrome p450 in a method of treating aids
10/02/2002EP0841946B1 Methods for treatment of allergic asthma
10/02/2002EP0793503B1 Use of the hepatocyte growth factor to induce proliferation and differentiation of hemopoietic cells
10/02/2002EP0792281B1 Process for purification of factor viii
10/02/2002EP0757249B1 Method of determining the suppressor cell component of the immune status of an individual and means for carrying out the same
10/02/2002EP0717750B1 Double-stranded peptide nucleic acids
10/02/2002EP0691988B1 Inhibitor of stem cell proliferation and uses thereof
10/02/2002EP0668933B1 Use of methioninase as an antitumor agent in anti-methionine chemotherapy
10/02/2002EP0651636B1 Chemotherapy for cancer
10/02/2002EP0600930B1 Diagnosis and treatment of autoimmune diseases
10/02/2002DE10113513A1 Drug combination of kinase inhibitor and neurotropic factor, useful for treating and/or preventing nerve and/or glial cell damage, e.g. associated with neurodegenerative diseases
10/02/2002DE10112825A1 HESylierung von Wirkstoffen in wässriger Lösung HESylation of drugs in aqueous solution
10/02/2002DE10112617A1 Verwendung eines C1-Esterase-Inhibitors zur Verhinderung oder Verzögerung der Abstoßung von Xenotransplantaten in Säugetieren Use of a C1-esterase inhibitor to prevent or delay the rejection of xenotransplants in mammals
10/02/2002CN1372598A Methods of inducing cell death
10/02/2002CN1372594A OX2 receptor homologs
10/02/2002CN1372570A Modified exendin and exendin agonists
10/02/2002CN1372569A Keratinocyte growth factor-2
10/02/2002CN1372568A Vaccin
10/02/2002CN1372567A Method for isolating and purifying grass pollen allergens
10/02/2002CN1372566A Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
10/02/2002CN1372553A Novel thiazine or pyrazine derivatives
10/02/2002CN1372543A new vitamin derivatives with cyclic substructures in the side chains, method and intermediates for their production and their use in the preparation of medicaments
10/02/2002CN1372475A Combination therapy of angiotension converting enzyme inhibitor and epoxy-steroidal aldosterone anatagonist for treatment of cardiovascular disease
10/02/2002CN1372472A Pernasally absorbable insulin preparations
10/02/2002CN1372471A Treatment of allergic rhinitis
10/02/2002CN1372450A Enhanced wound converage to enhance wound healing
10/02/2002CN1372000A Gene engineering body for somatostatin gene engineering subunit seedling
10/02/2002CN1371993A Superoxide dismutase conjugated substance and preparation method thereof
10/02/2002CN1371916A Human siali acid conjugated immunoglobulin-like agglutinant, its coding sequence and use
10/02/2002CN1371915A Novel human cell endocytic regulatory protein, its coding sequence and use
10/02/2002CN1371747A Anti-HIV medicine
10/02/2002CN1371725A Capsule for treating AIDS and tumor and preparation process thereof
10/02/2002CN1371723A Anti-tumor and antiviral medicine and production method thereof
10/02/2002CN1371617A Aloes collagen and method for making same
10/02/2002CN1091766C Prenyl transferase inhibitors
10/01/2002WO2001076630A1 Diagnostics and remedies for rheumatoid arthritis
10/01/2002US6458940 Genetic engineering
10/01/2002US6458939 Compositions and methods for the diagnosis, prevention, and treatment of neoplastic cell growth and proliferation
10/01/2002US6458934 Grafted complementarity determining regions to mouse monoclonal antibodies; amino acid replacements; autoimmune disease treatment and immunosuppressants; side effect reduction
10/01/2002US6458933 Specific for hla class ii invariant chain; side effect reduction of chemotherapy; drug clearance
10/01/2002US6458932 Dna cloning; gene expression; genetic engineering
10/01/2002US6458931 Immunoassay, immunotherapy; cancer; side effect reduction
10/01/2002US6458929 Myotilin, a novel actin-organizing protein
10/01/2002US6458927 Polypeptide with appetite regulating activity
10/01/2002US6458925 Peptide antagonists of zonulin and methods for use of the same
10/01/2002US6458924 POLYPEPTIDE DRUG; ANTIDIABETIC AGENT; Liraglutide
10/01/2002US6458923 Modified position (7) bradykinin antagonist peptides
10/01/2002US6458839 Modulation of inflammation related to columnar epithelia
10/01/2002US6458838 4-phenylbutyrate treatment of cells from both x-ald patients and x-ald knockout mice results in decreased levels of and increased .beta.-oxidation of very-long-chain fatty acids; increased expression of the peroxisomal protein aldrp; and
10/01/2002US6458785 Aids therapy
10/01/2002US6458769 Amorphous lisinopril having the formula (s)-1-(n.sup.2 -(1-carboxy-3-phenylpropyl))-l-lysyl)-l-proline, wherein amorphous lisinopril has a glass transition point (tg) when dry, measured by thermal mehanical analysis
10/01/2002US6458767 Use of peptides inhibitory for thrombospondin dependent TGF-β activation in the treatment of kidney disease
10/01/2002US6458766 A pharmaceutically acceptable salt or derivatives thereof, useful for preventing or treating viral and microbial infections, of oligopeotides
10/01/2002US6458765 Polypeptides as anticancer agents and against cell proliferation
10/01/2002US6458764 GRF analogs with increased biological potency
10/01/2002US6458763 Bone sialoprotein-based compositions for enhancing connective tissue repair
10/01/2002US6458762 The benefits and objects of administering hemoglobin as a treatment for blood vessel blockage are that it increases salvage of the area at risk, it stabilizes the circulatory system, as in cardiac ischemia,
10/01/2002US6458761 Synthetic, statistic thymic peptide combination and its use as a preparation with immunological and/or endocrinological effect
10/01/2002US6458760 Comprising administering to said patient a therapeutically effective amount of a compound which is a specific inhibitor of either cathepsin b or cathepsin l, but which is not as effective inhibitor of calpain
10/01/2002US6458759 Compositions and methods for isolating lung surfactant hydrophobic proteins SP-B and SP-C
10/01/2002US6458758 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
10/01/2002US6458591 Diabetes treatment
1 ... 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 ... 3163